Stevanato Group’s Post

🌟 Celebrating Our Clients' Success! 🌟 At Bend Bioscience, we promise to continue delivering exceptional service and innovative solutions to drive our clients' drug development success. Here's what our client had to say about their experience with us: Expertise & Innovation: "Your thorough work and great science made a world of difference in optimizing our Spray-dried Dispersion formulation and tablet prototyping." Problem-Solving Excellence: "Your ability to solve our problem statements was unparalleled. We felt confident every step of the way." Seamless Communication: "When it came time to communicate with our management, your detailed and transparent approach made it easy." Agility & Flexibility: "Fast, flexible, and easy to work with – you made our project a success!" Thank you to our amazing clients for trusting us with your critical projects. We look forward to many more successful collaborations! #ClientSuccess #Innovation #ProblemSolving #CDMO #SDDformulation 

Upcoming Webinar! Join HCmed Innovations Co., Ltd. and Intertek Melbourn to unlock the secrets of drug-nebulizer combination product. 📍DATE: 18 September 2024 (Two Sessions) 📍TOPIC: Development of Drug-Nebulizer Combination Products: Formulation and Device Considerations to Ensure Success Each session will cover: PART 1. Formulation and device considerations  - Selecting the right delivery platform.  - Advancements in mesh nebulizers and customization.  - Benefits of customizable mesh nebulizer platforms (e.g., Pulmogine, AdheResp).  - Key formulation factors: surface tension, viscosity, osmolality, and device constraints. PART 2. Understanding nebulizer performance - analytical and performance testing  - Regulatory considerations (EU vs US).  - Defining and measuring “good nebulizer performance”.  - Analytical methods and best practices. 🚀 To register and learn more about the webinar, click the link below: https://lnkd.in/eTTgsnxY #DrugNebulizer #CombinationDevelopment #DeliveryPlatform #MeshNebulizer #Analysis #Testing #Webinar

🌍💊🔬We're thrilled to share our latest news! Our innovative nanoenzalutamide tablet development is strengthened by the recent decision of the European Patent Office to maintain Medivation/Astellas formulation patent EP3725778 B1 covering Xtandi® tablet formulation, which represents a relevant barrier for Generics. 👩🔬🧪What sets our innovation apart? Our proprietary nanoenzalutamide tablet formulation has been developed as an alternative to the amorphous solid dispersion to enable a more patient-centric alternative to Xtandi® tablets and paves the way for a timely market entry as early as 2028. 🤝✔This shows the commitment to innovation of the ONConcept® consortium (Bluepharma, HELM AG and WELDING GmbH & Co. KG) in partnership with Nanoform and our relentless pursuit of advancing healthcare solutions. Stay tuned! + info: www.onconceptpharma.com #lifescience #productmanagement #lifesciences #pharmaceuticalindustry #research #development #valuechain #europeanunion #bepharma #pharma #quality #health #pharmanews #drugdevelopment #research #technology #oncology #lifesciences #productdeveloper #productdevelopment #businessdevelopment #marketing #sustainable #sustainability #network #sustainabledevelopment #cdmo

Excellence by Design, is the philosophy we adopt in our way of working.

Moving a medicine from lab to shelf is full of pitfalls. But how do you avoid the perils of #DrugDevelopment? ATUM's Leap-In®Transposase #CellLineDevelopment technology seamlessly integrates into process development and manufacturing with Avid Bioservices ensuring a smooth journey from drug discovery to commercialization. Let's talk! Connect with an ATUM expert: https://lnkd.in/gK8ViJsC

Vitti Labs! Is Vitti Labs an Imaginary 361 HCTP Product? Is Vitti Labs a Drug manufacture? Lately we've seen some WILD claims coming from Vitti Labs. Who isn't suppose to be selling product, and kind of doesn't anymore.. But they do? What does this mean for you? What does this mean for your malpractice? These are only my opinions please see the video for full disclaimer. https://lnkd.in/eisbB9sZ

🚀 𝗦𝗰𝗶𝗲𝗻𝗰𝗲 𝘀𝗲𝗿𝘃𝗲𝗱 𝗰𝗼𝗹𝗱!🧪 𝘌𝘷𝘪𝘥𝘦𝘯𝘵𝘪𝘤 𝘵𝘢𝘬𝘦𝘴 𝘤𝘰𝘯𝘵𝘳𝘰𝘭 𝘸𝘪𝘵𝘩 𝘰𝘯-𝘴𝘪𝘵𝘦 𝘭𝘢𝘣.   We're excited to open another chapter of Evidentic's history: the launch of our very own, first-of-its-kind lab! 🎉   Our new lab allows us to take complete control of the process, from sourcing high-quality drugs to repackaging them into convenient aliquots, storing them under optimal conditions, and finally shipping them directly to you. 📦   Currently, we are transitioning operations and expect to fully manage all aspects in-house soon. This new lab signifies a commitment to exceptional efficiency and unparalleled control. 🏆   𝗬𝗼𝘂𝗿 𝗯𝗲𝗻𝗲𝗳𝗶𝘁𝘀?   ⚡ Faster turnaround times: The in-house lab allows us to speed up the processes and to potentially reduce lead times for your critical research needs. 🕒   📏 Customized aliquot size: Our new lab empowers us to offer customized aliquots, minimizing waste and maximizing your research efficiency. 🌟   💬 Enhanced communication: Insourcing all units fosters closer collaboration, allowing us to better understand your needs and tailor our services accordingly. 🤝   This is just the beginning of an exciting new era for Evidentic. While maintaining our existing Berlin location, we're confident that our new lab in Potsdam will empower us to deliver even greater value and efficiency for your research endeavors. 🌐   Stay tuned for further updates, and the latest developments! 🔗   #Evidentic #Innovation #Science #Research #Laboratory #Efficiency #Pharmaceuticals #Biotechnology #Berlin #Potsdam #DrugDevelopment

𝗖𝗼𝗺𝗽𝗮𝗻𝗲𝘀 𝘁𝗼 𝗳𝗼𝗹𝗹𝗼𝘄 - 𝗗𝗿𝘂𝗴 𝗣𝗿𝗼𝗱𝘂𝗰𝘁 𝗗𝗲𝘃𝗲𝗹𝗼𝗽𝗺𝗲𝗻𝘁 The first time I came across the digiM solutions was at this year's DDF Summit in Berlin and had an insightful exchange with Anita Gashi and Joshua Lomeo. The more I learn about digit solutions the more I realize the support they can bring to the drug product development. If you do not yet know digiM, I believe it is of benefit to check and exchange with them. #formulation #drugproduct

Moving a medicine from lab to shelf is full of pitfalls. But how do you avoid the perils of #DrugDevelopment? ATUM's Leap-In® Transposase #CellLineDevelopment technology seamlessly integrates into process development and manufacturing with Avid Bioservices ensuring a smooth journey from drug discovery to commercialization. Let's talk! Connect with an ATUM expert: https://lnkd.in/gK8ViJsC

Thoughts on this? >> Evofem inks women’s health deal; AusperBio brings in $37M >> Comment below! >>> lqventures.com #strategy #competitiveintelligence #marketing #pharmaceutical #pharma #biotech #productmarketing #healthcare